REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medmate Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Medmate Pharma Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Medmate Pharma Private Limited is an unlisted company, incorporated on 08/01/2008. It has its registered office in the State of Kerala, India. Company's corporate identification number (CIN) is U24239KL2008PTC021657 and registration number is 021657. The company is a trade company, it is engaged in wholesale trading.

Legal Address
41/1859, Veekshanam Road Ernakulam
Ernakulam; Kerala; Postal Code: 682018

Contact Details: Purchase the Medmate Pharma Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Medmate Pharma Private Limited report to view the information.
Outstanding Shares:
Purchase the Medmate Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Medmate Pharma Private Limited report to view the information.
Incorporation Date:
January 08, 2008
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Medmate Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
24.42%▲
Total operating revenue
24.23%▲
Operating profit (EBIT)
-5.87%▼
EBITDA
-5.97%▼
Net Profit (Loss) for the Period
-5.69%▼
Total assets
-9%▼
Total equity
13.06%▲
Operating Profit Margin (ROS)
-1.12%▼
Net Profit Margin
-0.82%▼
Return on Equity (ROE)
-2.29%▼
Debt to Equity Ratio
-3.09%▼
Quick Ratio
1.01%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo